News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
727,071 Results
Type
Article (42468)
Company Profile (328)
Press Release (684275)
Multimedia
Podcasts (60)
Webinars (13)
Section
Business (211969)
Career Advice (2078)
Deals (36520)
Drug Delivery (105)
Drug Development (82965)
Employer Resources (177)
FDA (16589)
Job Trends (15446)
News (356802)
Policy (33491)
Tag
Academia (2667)
Academic (1)
Accelerated approval (5)
Adcomms (20)
Allergies (90)
Alliances (51796)
ALS (92)
Alzheimer's disease (1422)
Antibody-drug conjugate (ADC) (140)
Approvals (16595)
Artificial intelligence (282)
Autoimmune disease (23)
Automation (16)
Bankruptcy (364)
Best Places to Work (11989)
BIOSECURE Act (20)
Biosimilars (112)
Biotechnology (225)
Bladder cancer (80)
Brain cancer (28)
Breast cancer (281)
Cancer (2352)
Cardiovascular disease (181)
Career advice (1739)
Career pathing (31)
CAR-T (157)
Cell therapy (448)
Cervical cancer (20)
Clinical research (67504)
Collaboration (883)
Company closure (1)
Compensation (549)
Complete response letters (21)
COVID-19 (2707)
CRISPR (43)
C-suite (258)
Cystic fibrosis (100)
Data (2256)
Decentralized trials (2)
Denatured (24)
Depression (49)
Diabetes (279)
Diagnostics (6571)
Digital health (18)
Diversity (8)
Diversity, equity & inclusion (45)
Drug discovery (124)
Drug pricing (103)
Drug shortages (26)
Duchenne muscular dystrophy (95)
Earnings (88819)
Editorial (41)
Employer branding (22)
Employer resources (151)
Events (119833)
Executive appointments (762)
FDA (17909)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (8)
Funding (776)
Gene editing (110)
Generative AI (24)
Gene therapy (327)
GLP-1 (747)
Government (4544)
Grass and pollen (5)
Guidances (79)
Healthcare (19462)
Huntington's disease (24)
IgA nephropathy (29)
Immunology and inflammation (119)
Indications (30)
Infectious disease (2852)
Inflammatory bowel disease (143)
Inflation Reduction Act (8)
Influenza (51)
Intellectual property (100)
Interviews (320)
IPO (16939)
IRA (42)
Job creations (3893)
Job search strategy (1478)
Kidney cancer (10)
Labor market (38)
Layoffs (489)
Leadership (19)
Legal (8100)
Liver cancer (79)
Lung cancer (333)
Lymphoma (156)
Machine learning (7)
Management (58)
Manufacturing (325)
MASH (70)
Medical device (13878)
Medtech (13883)
Mergers & acquisitions (20146)
Metabolic disorders (713)
Multiple sclerosis (83)
NASH (18)
Neurodegenerative disease (96)
Neuropsychiatric disorders (29)
Neuroscience (1983)
NextGen: Class of 2025 (6711)
Non-profit (4626)
Now hiring (39)
Obesity (378)
Opinion (223)
Ovarian cancer (78)
Pain (90)
Pancreatic cancer (88)
Parkinson's disease (155)
Partnered (22)
Patents (241)
Patient recruitment (115)
Peanut (49)
People (59973)
Pharmaceutical (80)
Pharmacy benefit managers (18)
Phase I (21040)
Phase II (29699)
Phase III (22179)
Pipeline (1238)
Policy (147)
Postmarket research (2599)
Preclinical (8930)
Press Release (72)
Prostate cancer (111)
Psychedelics (33)
Radiopharmaceuticals (260)
Rare diseases (389)
Real estate (6322)
Recruiting (69)
Regulatory (22996)
Reports (46)
Research institute (2435)
Resumes & cover letters (356)
Rett syndrome (5)
RNA editing (5)
RSV (43)
Schizophrenia (74)
Series A (134)
Series B (90)
Service/supplier (14)
Sickle cell disease (54)
Special edition (14)
Spinal muscular atrophy (150)
Sponsored (33)
Startups (3749)
State (2)
Stomach cancer (15)
Supply chain (71)
Tariffs (43)
The Weekly (34)
Vaccines (729)
Venture capitalists (42)
Weight loss (247)
Women's health (36)
Worklife (16)
Date
Today (176)
Last 7 days (837)
Last 30 days (2763)
Last 365 days (33934)
2025 (11359)
2024 (36385)
2023 (41246)
2022 (52530)
2021 (57142)
2020 (55728)
2019 (48212)
2018 (36330)
2017 (33415)
2016 (33131)
2015 (39193)
2014 (32841)
2013 (27824)
2012 (30045)
2011 (30667)
2010 (28695)
Location
Africa (792)
Alabama (53)
Alaska (7)
Arizona (240)
Arkansas (13)
Asia (40670)
Australia (6790)
California (6321)
Canada (2050)
China (554)
Colorado (271)
Connecticut (284)
Delaware (155)
Europe (88720)
Florida (925)
Georgia (217)
Hawaii (1)
Idaho (58)
Illinois (579)
India (28)
Indiana (326)
Iowa (11)
Japan (170)
Kansas (108)
Kentucky (26)
Louisiana (11)
Maine (62)
Maryland (926)
Massachusetts (4772)
Michigan (242)
Minnesota (411)
Mississippi (2)
Missouri (89)
Montana (30)
Nebraska (25)
Nevada (65)
New Hampshire (67)
New Jersey (1803)
New Mexico (31)
New York (1793)
North Carolina (1035)
North Dakota (9)
Northern California (2755)
Ohio (213)
Oklahoma (15)
Oregon (36)
Pennsylvania (1413)
Puerto Rico (12)
Rhode Island (33)
South America (1182)
South Carolina (23)
South Dakota (1)
Southern California (2373)
Tennessee (102)
Texas (939)
United States (24013)
Utah (189)
Virginia (158)
Washington D.C. (67)
Washington State (571)
West Virginia (3)
Wisconsin (59)
727,071 Results for "krs global biotechnology inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Policy
Akoya Biosciences and Shanghai KR Pharmtech Announce Chinese Regulatory Agency Premarket Approval for KR-HT5 in China to Support Next Generation Pathology Clinical WorkflowsKR-HT5 is based on Akoya’s PhenoImager® HT Platform
Akoya Biosciences, Inc., The Spatial Biology Company®, and Shanghai KR Pharmtech have jointly announced that KR-HT5, which Akoya Biosciences co-developed with Shanghai KR Pharmtech utilizing the PhenoImager HT technology as its foundation, has received premarket approval from China’s National Medical Products Administration to support next generation pathology clinical workflows.
May 2, 2024
·
4 min read
Press Releases
Puma Biotechnology to Present at Barclays Annual Global Healthcare Conference
March 5, 2025
·
2 min read
Press Releases
Puma Biotechnology to Present at Barclays 27th Annual Global Healthcare Conference
March 5, 2025
·
2 min read
Press Releases
Spiderwort Biotechnologies Inc. Announces Status of Biocompatibility Testing for CelluJuve®
April 30, 2025
·
3 min read
Press Releases
Healthcare Integrated Technologies Inc. Announces Corporate Name Change to SafeSpace Global Corporation and Ticker Symbol Update
April 24, 2025
·
2 min read
Press Releases
COSCIENS Biopharma Inc. Appoints Global Consumer Products and Biosciences Executive, Anna Biehn as Chief Executive Officer
April 14, 2025
·
7 min read
Press Releases
DaVita Inc. to Participate in the Barclays Global Healthcare Conference 2025
March 6, 2025
·
1 min read
Press Releases
AEON Biopharma, Inc. to Participate in the Leerink Global Healthcare Conference
March 4, 2025
·
1 min read
Press Releases
HOPE Therapeutics, Inc. and NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Announce Signing of a Term Sheet for Strategic Investment from a Global Medical Device Manufacturer into HOPE
April 3, 2025
·
5 min read
Press Releases
UNITY Biotechnology, Inc. Reports First Quarter 2025 Financial Results and Business Updates
April 23, 2025
·
6 min read
1 of 72,708
Next
